Blood eosinophils and mortality in patients with acute respiratory distress syndrome: A propensity score matching analysis
Hao-tian Chen, Jian-feng Xu, Xiao-xia Huang, Ni-ya Zhou, Yong-kui Wang, Yue Mao
Table 2 Comparisons of outcome characteristics between the EOS counts <2% and EOS counts ≥2% groups
Variables Total (n=2,567) Patients who used corticosteroids (n=436) Patients who did not use corticosteroids (n=2,131)
EOS counts <2% (n=2,110) EOS counts ≥2%
(n=457)
P EOS counts <2% (n=389) EOS counts ≥2% (n=47) P EOS counts <2% (n=1,721) EOS counts ≥2% (n=410) P
28-day mortality, n (%) 536 (25.40) 85 (18.60) 0.002 139 (35.73) 21 (44.68) 0.229 397 (23.07) 64 (15.61) 0.001
ICU mortality, n (%) 448 (21.23) 71 (15.54) 0.006 125 (32.13) 22 (46.81) 0.144 323 (18.77) 49 (11.95) 0.001
Hospital mortality, n (%) 527 (24.98) 81 (17.72) 0.001 140 (35.99) 21 (44.68) 0.244 387 (22.49) 60 (14.63) <0.001
Length of ICU stay (days) 6.17 (3.67-11.92) 6.21 (3.58-12.38) 0.918 7.29 (4.33-14.13) 7.33 (3.71-12.13) 0.538 5.96 (3.46-11.33) 6.08 (3.46-12.63) 0.629
Length of hospital stay (days) 12.00 (7.25-20.25) 11.92 (7.38-21.83) 0.340 14.17 (8.25-23.83) 12.21 (6.88-16.92) 0.094 11.75 (7.16-19.00) 11.89 (7.38-22.88) 0.392